nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ABCB1—peripheral nervous system neoplasm	0.188	1	CbGaD
Desipramine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.141	0.236	CbGbCtD
Desipramine—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.0883	0.148	CbGbCtD
Desipramine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0429	0.0718	CbGbCtD
Desipramine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0421	0.0704	CbGbCtD
Desipramine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0417	0.0698	CbGbCtD
Desipramine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0279	0.0467	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0244	0.0407	CbGbCtD
Desipramine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.023	0.0385	CbGbCtD
Desipramine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0176	0.0295	CbGbCtD
Desipramine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0154	0.0258	CbGbCtD
Desipramine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0154	0.0258	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0141	0.0236	CbGbCtD
Desipramine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.012	0.02	CbGbCtD
Desipramine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0119	0.0199	CbGbCtD
Desipramine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0107	0.0179	CbGbCtD
Desipramine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00923	0.0154	CbGbCtD
Desipramine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00858	0.0144	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00802	0.0134	CbGbCtD
Desipramine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00689	0.0115	CbGbCtD
Desipramine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00658	0.011	CbGbCtD
Desipramine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00613	0.0103	CbGbCtD
Desipramine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00603	0.0101	CbGbCtD
Desipramine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00411	0.00687	CbGbCtD
Desipramine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00394	0.00659	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00387	0.00648	CbGbCtD
Desipramine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00361	0.00604	CbGbCtD
Desipramine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00359	0.138	CbGeAlD
Desipramine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00246	0.00412	CbGbCtD
Desipramine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00131	0.0504	CbGeAlD
Desipramine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00123	0.0471	CbGeAlD
Desipramine—SLC6A3—nerve—peripheral nervous system neoplasm	0.000989	0.0379	CbGeAlD
Desipramine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.000977	0.0375	CbGeAlD
Desipramine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.000962	0.0369	CbGeAlD
Desipramine—HTR2C—ganglion—peripheral nervous system neoplasm	0.000944	0.0362	CbGeAlD
Desipramine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.000936	0.0359	CbGeAlD
Desipramine—HTR2A—pons—peripheral nervous system neoplasm	0.000925	0.0355	CbGeAlD
Desipramine—SLC22A3—tongue—peripheral nervous system neoplasm	0.00091	0.0349	CbGeAlD
Desipramine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000895	0.0343	CbGeAlD
Desipramine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.000831	0.212	CrCbGaD
Desipramine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000798	0.0306	CbGeAlD
Desipramine—HTR1A—ganglion—peripheral nervous system neoplasm	0.000795	0.0305	CbGeAlD
Desipramine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000788	0.0302	CbGeAlD
Desipramine—DRD2—nerve—peripheral nervous system neoplasm	0.000727	0.0279	CbGeAlD
Desipramine—DRD2—ganglion—peripheral nervous system neoplasm	0.000718	0.0275	CbGeAlD
Desipramine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000669	0.0257	CbGeAlD
Desipramine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.000514	0.131	CrCbGaD
Desipramine—HTR2A—nerve—peripheral nervous system neoplasm	0.00048	0.0184	CbGeAlD
Desipramine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000474	0.0182	CbGeAlD
Desipramine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00047	0.12	CrCbGaD
Desipramine—SMPD1—cerebellum—peripheral nervous system neoplasm	0.00046	0.0176	CbGeAlD
Desipramine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000452	0.0173	CbGeAlD
Desipramine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000426	0.0163	CbGeAlD
Desipramine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000425	0.0163	CbGeAlD
Desipramine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000413	0.0158	CbGeAlD
Desipramine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00041	0.0157	CbGeAlD
Desipramine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000389	0.0149	CbGeAlD
Desipramine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000385	0.0984	CrCbGaD
Desipramine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000345	0.0132	CbGeAlD
Desipramine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000342	0.0131	CbGeAlD
Desipramine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000328	0.0126	CbGeAlD
Desipramine—DRD2—brainstem—peripheral nervous system neoplasm	0.000312	0.012	CbGeAlD
Desipramine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.00031	0.0119	CbGeAlD
Desipramine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000279	0.0107	CbGeAlD
Desipramine—Protriptyline—ABCB1—peripheral nervous system neoplasm	0.000271	0.0691	CrCbGaD
Desipramine—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.000247	0.00948	CbGeAlD
Desipramine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00166	CcSEcCtD
Desipramine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000217	0.00165	CcSEcCtD
Desipramine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00165	CcSEcCtD
Desipramine—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.000217	0.00831	CbGeAlD
Desipramine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000216	0.00164	CcSEcCtD
Desipramine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000215	0.00164	CcSEcCtD
Desipramine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000214	0.00163	CcSEcCtD
Desipramine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000212	0.00161	CcSEcCtD
Desipramine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00161	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.0016	CcSEcCtD
Desipramine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00021	0.0016	CcSEcCtD
Desipramine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.0016	CcSEcCtD
Desipramine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00021	0.0016	CcSEcCtD
Desipramine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000209	0.00803	CbGeAlD
Desipramine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00159	CcSEcCtD
Desipramine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000209	0.00159	CcSEcCtD
Desipramine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00159	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000208	0.00158	CcSEcCtD
Desipramine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000208	0.00158	CcSEcCtD
Desipramine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00158	CcSEcCtD
Desipramine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000207	0.00158	CcSEcCtD
Desipramine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000207	0.00158	CcSEcCtD
Desipramine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00157	CcSEcCtD
Desipramine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000206	0.0079	CbGeAlD
Desipramine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00156	CcSEcCtD
Desipramine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000205	0.00156	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00156	CcSEcCtD
Desipramine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000204	0.00155	CcSEcCtD
Desipramine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000202	0.00154	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00154	CcSEcCtD
Desipramine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00153	CcSEcCtD
Desipramine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00153	CcSEcCtD
Desipramine—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000201	0.0512	CrCbGaD
Desipramine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000201	0.00153	CcSEcCtD
Desipramine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000201	0.00153	CcSEcCtD
Desipramine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.0002	0.00152	CcSEcCtD
Desipramine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.00152	CcSEcCtD
Desipramine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000198	0.00151	CcSEcCtD
Desipramine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.0015	CcSEcCtD
Desipramine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.0015	CcSEcCtD
Desipramine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000197	0.0015	CcSEcCtD
Desipramine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000197	0.0015	CcSEcCtD
Desipramine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00149	CcSEcCtD
Desipramine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000195	0.00149	CcSEcCtD
Desipramine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000195	0.00148	CcSEcCtD
Desipramine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000194	0.00148	CcSEcCtD
Desipramine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000194	0.00148	CcSEcCtD
Desipramine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000194	0.00147	CcSEcCtD
Desipramine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00147	CcSEcCtD
Desipramine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000192	0.00146	CcSEcCtD
Desipramine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000192	0.00146	CcSEcCtD
Desipramine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00146	CcSEcCtD
Desipramine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.00145	CcSEcCtD
Desipramine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00145	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.00144	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.00144	CcSEcCtD
Desipramine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000189	0.00144	CcSEcCtD
Desipramine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000188	0.00143	CcSEcCtD
Desipramine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000188	0.00719	CbGeAlD
Desipramine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00142	CcSEcCtD
Desipramine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Rash—Topotecan—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Desipramine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000186	0.0475	CrCbGaD
Desipramine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Headache—Topotecan—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Desipramine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000185	0.0014	CcSEcCtD
Desipramine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000184	0.0014	CcSEcCtD
Desipramine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000184	0.0014	CcSEcCtD
Desipramine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.0014	CcSEcCtD
Desipramine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000184	0.0014	CcSEcCtD
Desipramine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000183	0.0014	CcSEcCtD
Desipramine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00139	CcSEcCtD
Desipramine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000183	0.00139	CcSEcCtD
Desipramine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00139	CcSEcCtD
Desipramine—Rash—Melphalan—peripheral nervous system neoplasm	0.000182	0.00139	CcSEcCtD
Desipramine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000182	0.00139	CcSEcCtD
Desipramine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00137	CcSEcCtD
Desipramine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000179	0.00136	CcSEcCtD
Desipramine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000177	0.00135	CcSEcCtD
Desipramine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00134	CcSEcCtD
Desipramine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00134	CcSEcCtD
Desipramine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00134	CcSEcCtD
Desipramine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000175	0.00134	CcSEcCtD
Desipramine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000175	0.00133	CcSEcCtD
Desipramine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00133	CcSEcCtD
Desipramine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00133	CcSEcCtD
Desipramine—Maprotiline—ABCB1—peripheral nervous system neoplasm	0.000173	0.0441	CrCbGaD
Desipramine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00131	CcSEcCtD
Desipramine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000172	0.00131	CcSEcCtD
Desipramine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000172	0.00131	CcSEcCtD
Desipramine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00017	0.00653	CbGeAlD
Desipramine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00129	CcSEcCtD
Desipramine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00017	0.00129	CcSEcCtD
Desipramine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Desipramine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Desipramine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Desipramine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000165	0.00126	CcSEcCtD
Desipramine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00125	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.00125	CcSEcCtD
Desipramine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000162	0.00123	CcSEcCtD
Desipramine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00121	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000158	0.0012	CcSEcCtD
Desipramine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.0012	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00119	CcSEcCtD
Desipramine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000156	0.00119	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000156	0.00119	CcSEcCtD
Desipramine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00118	CcSEcCtD
Desipramine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000154	0.00117	CcSEcCtD
Desipramine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000154	0.0059	CbGeAlD
Desipramine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000154	0.00117	CcSEcCtD
Desipramine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000152	0.00585	CbGeAlD
Desipramine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00116	CcSEcCtD
Desipramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.00116	CcSEcCtD
Desipramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00116	CcSEcCtD
Desipramine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.00115	CcSEcCtD
Desipramine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000151	0.0385	CrCbGaD
Desipramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000151	0.00115	CcSEcCtD
Desipramine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00114	CcSEcCtD
Desipramine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000149	0.00114	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00114	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00113	CcSEcCtD
Desipramine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00113	CcSEcCtD
Desipramine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000148	0.00113	CcSEcCtD
Desipramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.00112	CcSEcCtD
Desipramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000146	0.00111	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00111	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.0011	CcSEcCtD
Desipramine—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000143	0.0055	CbGeAlD
Desipramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000143	0.00109	CcSEcCtD
Desipramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000142	0.00108	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00108	CcSEcCtD
Desipramine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000142	0.00108	CcSEcCtD
Desipramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00107	CcSEcCtD
Desipramine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00107	CcSEcCtD
Desipramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00107	CcSEcCtD
Desipramine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.00106	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00105	CcSEcCtD
Desipramine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000138	0.00105	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00105	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00105	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000137	0.00104	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000137	0.00104	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00104	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00104	CcSEcCtD
Desipramine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000136	0.00104	CcSEcCtD
Desipramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000136	0.00103	CcSEcCtD
Desipramine—Rash—Vincristine—peripheral nervous system neoplasm	0.000135	0.00103	CcSEcCtD
Desipramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000135	0.00103	CcSEcCtD
Desipramine—Headache—Vincristine—peripheral nervous system neoplasm	0.000134	0.00102	CcSEcCtD
Desipramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.001	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.001	CcSEcCtD
Desipramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000986	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000971	CcSEcCtD
Desipramine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000127	0.000968	CcSEcCtD
Desipramine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000967	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000964	CcSEcCtD
Desipramine—Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.000126	0.0322	CrCbGaD
Desipramine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000959	CcSEcCtD
Desipramine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000124	0.000947	CcSEcCtD
Desipramine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000123	0.000934	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00093	CcSEcCtD
Desipramine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00092	CcSEcCtD
Desipramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000916	CcSEcCtD
Desipramine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000908	CcSEcCtD
Desipramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000908	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000119	0.000903	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000898	CcSEcCtD
Desipramine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000894	CcSEcCtD
Desipramine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000117	0.00448	CbGeAlD
Desipramine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000888	CcSEcCtD
Desipramine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000115	0.000873	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000861	CcSEcCtD
Desipramine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000856	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000854	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000852	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000841	CcSEcCtD
Desipramine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00011	0.000839	CcSEcCtD
Desipramine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000833	CcSEcCtD
Desipramine—Rash—Etoposide—peripheral nervous system neoplasm	0.000109	0.000832	CcSEcCtD
Desipramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000109	0.000831	CcSEcCtD
Desipramine—Headache—Etoposide—peripheral nervous system neoplasm	0.000109	0.000827	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000821	CcSEcCtD
Desipramine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000818	CcSEcCtD
Desipramine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000106	0.0271	CrCbGaD
Desipramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000801	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000791	CcSEcCtD
Desipramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000785	CcSEcCtD
Desipramine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000103	0.000784	CcSEcCtD
Desipramine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000783	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000778	CcSEcCtD
Desipramine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000101	0.00389	CbGeAlD
Desipramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000771	CcSEcCtD
Desipramine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000769	CcSEcCtD
Desipramine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000763	CcSEcCtD
Desipramine—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000756	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000755	CcSEcCtD
Desipramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000746	CcSEcCtD
Desipramine—Trimipramine—ABCB1—peripheral nervous system neoplasm	9.77e-05	0.0249	CrCbGaD
Desipramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000741	CcSEcCtD
Desipramine—Oedema—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.00074	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000727	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000724	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000724	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000722	CcSEcCtD
Desipramine—Promethazine—ABCB1—peripheral nervous system neoplasm	9.41e-05	0.024	CrCbGaD
Desipramine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000712	CcSEcCtD
Desipramine—Doxepin—ABCB1—peripheral nervous system neoplasm	9.31e-05	0.0238	CrCbGaD
Desipramine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000706	CcSEcCtD
Desipramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000705	CcSEcCtD
Desipramine—CYP2D6—cerebellum—peripheral nervous system neoplasm	9.25e-05	0.00355	CbGeAlD
Desipramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000698	CcSEcCtD
Desipramine—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000691	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.00069	CcSEcCtD
Desipramine—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000685	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.00067	CcSEcCtD
Desipramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000669	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000668	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000664	CcSEcCtD
Desipramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000658	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000653	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000651	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000643	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.00064	CcSEcCtD
Desipramine—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000638	CcSEcCtD
Desipramine—Constipation—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000633	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000619	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000615	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.00061	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000609	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000603	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000595	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.00059	CcSEcCtD
Desipramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000588	CcSEcCtD
Desipramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000585	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000585	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000585	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000564	CcSEcCtD
Desipramine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	7.28e-05	0.0186	CrCbGaD
Desipramine—Imipramine—ABCB1—peripheral nervous system neoplasm	7.24e-05	0.0185	CrCbGaD
Desipramine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	7.2e-05	0.0184	CrCbGaD
Desipramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000544	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000541	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000541	CcSEcCtD
Desipramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000531	CcSEcCtD
Desipramine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000523	CcSEcCtD
Desipramine—ABCB1—cerebellum—peripheral nervous system neoplasm	6.65e-05	0.00255	CbGeAlD
Desipramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000506	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000491	CcSEcCtD
Desipramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000489	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000484	CcSEcCtD
Desipramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.00047	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000468	CcSEcCtD
Desipramine—Rash—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000467	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000466	CcSEcCtD
Desipramine—Headache—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000464	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000453	CcSEcCtD
Desipramine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000439	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000435	CcSEcCtD
Desipramine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000432	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000431	CcSEcCtD
Desipramine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000429	CcSEcCtD
Desipramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000407	CcSEcCtD
Desipramine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.11e-05	0.000208	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000208	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.1e-05	0.000208	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000207	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.09e-05	0.000205	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.09e-05	0.000205	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.08e-05	0.000204	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000204	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.08e-05	0.000203	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.08e-05	0.000203	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.08e-05	0.000202	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.07e-05	0.000202	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.07e-05	0.000201	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	1.06e-05	0.0002	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.05e-05	0.000198	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.05e-05	0.000198	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.000197	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.000194	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000194	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.03e-05	0.000194	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.000193	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.02e-05	0.000193	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	0.000192	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.00019	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00019	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	9.98e-06	0.000188	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.87e-06	0.000186	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.75e-06	0.000183	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	9.69e-06	0.000182	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	9.67e-06	0.000182	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.65e-06	0.000182	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.62e-06	0.000181	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.59e-06	0.00018	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.57e-06	0.00018	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.54e-06	0.000179	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.51e-06	0.000179	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	9.49e-06	0.000178	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.48e-06	0.000178	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.46e-06	0.000178	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.44e-06	0.000178	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.42e-06	0.000177	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.39e-06	0.000177	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.33e-06	0.000175	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.31e-06	0.000175	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.28e-06	0.000174	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.25e-06	0.000174	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.22e-06	0.000173	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.16e-06	0.000172	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.03e-06	0.00017	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.92e-06	0.000168	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.91e-06	0.000168	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.89e-06	0.000167	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.88e-06	0.000167	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.87e-06	0.000167	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.84e-06	0.000166	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.81e-06	0.000166	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.73e-06	0.000164	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.51e-06	0.00016	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.36e-06	0.000157	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	8.32e-06	0.000156	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.29e-06	0.000156	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	8.19e-06	0.000154	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.16e-06	0.000154	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.15e-06	0.000153	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.15e-06	0.000153	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	8.15e-06	0.000153	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.14e-06	0.000153	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.11e-06	0.000153	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.09e-06	0.000152	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.01e-06	0.000151	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.01e-06	0.000151	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	8e-06	0.00015	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.99e-06	0.00015	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.81e-06	0.000147	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.7e-06	0.000145	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.63e-06	0.000143	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.55e-06	0.000142	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	7.53e-06	0.000142	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.52e-06	0.000141	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.19e-06	0.000135	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	7.08e-06	0.000133	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.98e-06	0.000131	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.86e-06	0.000129	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.83e-06	0.000128	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.71e-06	0.000126	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.68e-06	0.000126	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.64e-06	0.000125	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.61e-06	0.000124	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.56e-06	0.000123	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.53e-06	0.000123	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.38e-06	0.00012	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.33e-06	0.000119	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	6.29e-06	0.000118	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.22e-06	0.000117	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	6.17e-06	0.000116	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.14e-06	0.000115	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.09e-06	0.000115	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.05e-06	0.000114	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	6e-06	0.000113	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6e-06	0.000113	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.96e-06	0.000112	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.86e-06	0.00011	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.83e-06	0.00011	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.8e-06	0.000109	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.78e-06	0.000109	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.77e-06	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.76e-06	0.000108	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.76e-06	0.000108	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.74e-06	0.000108	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.74e-06	0.000108	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.72e-06	0.000108	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.67e-06	0.000107	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.67e-06	0.000107	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.66e-06	0.000107	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.65e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.64e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.62e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.56e-06	0.000105	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.5e-06	0.000103	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.42e-06	0.000102	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.3e-06	9.97e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.26e-06	9.9e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.18e-06	9.75e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.16e-06	9.7e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.11e-06	9.61e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.03e-06	9.46e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5e-06	9.4e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.97e-06	9.34e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.92e-06	9.26e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.92e-06	9.25e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.9e-06	9.21e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.88e-06	9.19e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.86e-06	9.14e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.86e-06	9.14e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.83e-06	9.09e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.81e-06	9.05e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.81e-06	9.05e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.81e-06	9.04e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.75e-06	8.93e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.73e-06	8.89e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.71e-06	8.85e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.7e-06	8.84e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.68e-06	8.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.68e-06	8.81e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.63e-06	8.71e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	4.57e-06	8.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.55e-06	8.56e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.51e-06	8.48e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.48e-06	8.43e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.48e-06	8.42e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.47e-06	8.41e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.45e-06	8.38e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.44e-06	8.35e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.41e-06	8.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.4e-06	8.27e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.31e-06	8.11e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.29e-06	8.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.29e-06	8.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.22e-06	7.94e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.21e-06	7.92e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.2e-06	7.9e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.18e-06	7.87e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.17e-06	7.84e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.14e-06	7.79e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.13e-06	7.77e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.12e-06	7.76e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.1e-06	7.72e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.09e-06	7.7e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.08e-06	7.68e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.07e-06	7.65e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.07e-06	7.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.06e-06	7.63e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.04e-06	7.61e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.03e-06	7.59e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.03e-06	7.58e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.03e-06	7.58e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.99e-06	7.51e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.94e-06	7.42e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.92e-06	7.38e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.85e-06	7.23e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.84e-06	7.23e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.79e-06	7.12e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.78e-06	7.11e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.76e-06	7.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.73e-06	7.01e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.72e-06	6.99e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.71e-06	6.98e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.71e-06	6.97e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.69e-06	6.95e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.68e-06	6.93e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.68e-06	6.92e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.67e-06	6.91e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.66e-06	6.88e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.66e-06	6.88e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.52e-06	6.62e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.46e-06	6.51e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.41e-06	6.41e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.4e-06	6.4e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.39e-06	6.38e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.38e-06	6.36e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.35e-06	6.29e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.25e-06	6.11e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.23e-06	6.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.17e-06	5.97e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.17e-06	5.96e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.16e-06	5.94e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.15e-06	5.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.15e-06	5.92e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.12e-06	5.86e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.11e-06	5.85e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.09e-06	5.8e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-06	5.7e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.02e-06	5.68e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.02e-06	5.67e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	3e-06	5.65e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.95e-06	5.55e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.89e-06	5.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.87e-06	5.4e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.83e-06	5.31e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	2.78e-06	5.23e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.66e-06	5.01e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.65e-06	4.98e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.61e-06	4.91e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.61e-06	4.9e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.61e-06	4.9e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.6e-06	4.89e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.59e-06	4.88e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.58e-06	4.86e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.56e-06	4.81e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.55e-06	4.79e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.53e-06	4.77e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.53e-06	4.77e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.49e-06	4.69e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.49e-06	4.68e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.48e-06	4.66e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.47e-06	4.65e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.45e-06	4.6e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.25e-06	4.22e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.24e-06	4.21e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.2e-06	4.14e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.2e-06	4.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.2e-06	4.13e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.19e-06	4.12e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.18e-06	4.11e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.16e-06	4.07e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.7e-06	3.19e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.66e-06	3.12e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	2.94e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	2.49e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.02e-06	1.92e-05	CbGpPWpGaD
